Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Role of 18F-PSMA PET in Prostate Cancer Diagnosis in Equivocal MRI
Sponsor: Chinese University of Hong Kong
Summary
This study is a multi-center RCT to compare the clinically significant prostate cancer (csPCa) detection and/or change in clinical management in MRI guided (MRI arm) biopsy and MRI+18F-PSMA guided (Combined arm) biopsies in men with equivocal MRI prostate scans. If additional clinical value is shown by adding 18F-PSMA PET to equivocal MRI, then this should be the new standard of care.
Official title: The Role of 18F-PSMA PET in Prostate Cancer Diagnosis in Equivocal MRI: a Multi-center Randomised Controlled Trial
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
250
Start Date
2026-03-01
Completion Date
2028-03-31
Last Updated
2026-02-04
Healthy Volunteers
No
Conditions
Interventions
MRI+PSMA-guided approach
MRI+PSMA-guided approach prostate biopsy
MRI-guided approach
MRI-guided approach prostate biopsy
Locations (1)
Prince of Wales Hospital
Hong Kong, Hong Kong